Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues
摘要:
Salvinorin A is the most potent naturally occurring opioid agonist with a high selectivity and affinity for kappa-opioid receptor. To explore its structure-activity relationships, modifications at the C(4) position have been studied and a series of salvinorin A derivatives were prepared. These C(4)-modified salvinorin A analogues were screened for binding and functional activities at the human kappa-opioid receptor and several potent new agonists have been identified. (c) 2005 Elsevier Ltd. All rights reserved.
DOI:
10.1016/j.bmcl.2005.06.092
作为产物:
描述:
丹酚 A 在
吡啶 、 lithium iodide 作用下,
反应 36.0h,
以39%的产率得到hapten B
参考文献:
名称:
Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues
摘要:
Salvinorin A is the most potent naturally occurring opioid agonist with a high selectivity and affinity for kappa-opioid receptor. To explore its structure-activity relationships, modifications at the C(4) position have been studied and a series of salvinorin A derivatives were prepared. These C(4)-modified salvinorin A analogues were screened for binding and functional activities at the human kappa-opioid receptor and several potent new agonists have been identified. (c) 2005 Elsevier Ltd. All rights reserved.
Salvinorin A, a compound isolated from the plant Salvia divinorum, is a potent and highly selective agonist for the kappa Opioid receptor. For exploration of its structure and activity relationships, further modifications, such as reduction at the C(4) position, have been studied and a series of salvinorin A derivatives were prepared. These C(4) modified salvinorin A analogues were screened for binding and functional activities at the human K-opioid receptor and several new full agonists have been identified. (c) 2006 Elsevier Ltd. All rights reserved.
Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues
Salvinorin A is the most potent naturally occurring opioid agonist with a high selectivity and affinity for kappa-opioid receptor. To explore its structure-activity relationships, modifications at the C(4) position have been studied and a series of salvinorin A derivatives were prepared. These C(4)-modified salvinorin A analogues were screened for binding and functional activities at the human kappa-opioid receptor and several potent new agonists have been identified. (c) 2005 Elsevier Ltd. All rights reserved.